Skip to main content
Top
Published in: Pediatric Nephrology 10/2007

01-10-2007 | Original Article

Minimising changes in plasma calcium and magnesium concentrations during plasmapheresis

Authors: Rajesh G. Krishnan, Malcolm G. Coulthard

Published in: Pediatric Nephrology | Issue 10/2007

Login to get access

Abstract

Hypocalcaemic tetany is a known complication of plasmapheresis. It has two causes. Intravenously administered 4.5% human albumin solution (HAS) has no calcium or magnesium, so the replacement of plasma with this fluid depletes these ions. The citrate in fresh frozen plasma (FFP) chelates divalent cations, so the exchange with this at the end reduces the proportion of calcium and magnesium that is ionised. We studied the effect of supplementing HAS with 2 mmol/l calcium chloride and 0.8 mmol/l magnesium sulphate on the changes in ionised and total calcium and magnesium concentrations throughout plasmapheresis. The supplements prevented the falls in these concentrations that is otherwise seen during the HAS infusion, and, thus, the transient fall in ionised calcium concentration induced by the citrate in the FFP was not so profound, reaching 0.92 instead of 0.78 mmol/l (P = 0.002). Supplementation with calcium and magnesium during HAS maintains their balance and prevents tetany during the FFP infusion.
Literature
1.
go back to reference Reimann PM, Mason PD (1990) Plasmapheresis: technique and complications. Intensive Care Med 16:3–10CrossRef Reimann PM, Mason PD (1990) Plasmapheresis: technique and complications. Intensive Care Med 16:3–10CrossRef
2.
go back to reference Couriel D, Weinstein R (1994) Complications of therapeutic plasma exchange: a recent assessment. J Clin Apher 9:1–5CrossRef Couriel D, Weinstein R (1994) Complications of therapeutic plasma exchange: a recent assessment. J Clin Apher 9:1–5CrossRef
3.
go back to reference Mokrzycki MH, Kaplan AA (1994) Therapeutic plasma exchange: complications and management. Am J Kidney Dis 23:817–827CrossRef Mokrzycki MH, Kaplan AA (1994) Therapeutic plasma exchange: complications and management. Am J Kidney Dis 23:817–827CrossRef
4.
go back to reference Basic-Jukic N, Kes P, Glavas-Boras S, Brunetta B, Bubic-Filipi L, Puretic Z (2005) Complications of therapeutic plasma exchange: experience with 4857 treatments. Ther Apher Dial 9:391–395CrossRef Basic-Jukic N, Kes P, Glavas-Boras S, Brunetta B, Bubic-Filipi L, Puretic Z (2005) Complications of therapeutic plasma exchange: experience with 4857 treatments. Ther Apher Dial 9:391–395CrossRef
5.
go back to reference Weinstein R (1996) Prevention of citrate reactions during therapeutic plasma exchange by constant infusion of calcium gluconate with the return fluid. J Clin Apher 11:204–210CrossRef Weinstein R (1996) Prevention of citrate reactions during therapeutic plasma exchange by constant infusion of calcium gluconate with the return fluid. J Clin Apher 11:204–210CrossRef
Metadata
Title
Minimising changes in plasma calcium and magnesium concentrations during plasmapheresis
Authors
Rajesh G. Krishnan
Malcolm G. Coulthard
Publication date
01-10-2007
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 10/2007
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-007-0549-4

Other articles of this Issue 10/2007

Pediatric Nephrology 10/2007 Go to the issue